Explore LL-37 dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
LL-37 is the only known human cathelicidin antimicrobial peptide, produced by neutrophils and epithelial cells as part of the innate immune response. It is studied for its roles in immune modulation, wound healing, angiogenesis, and defense against bacterial biofilms. This data reveals the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when setting up their LL-37 reconstitution protocol.
18 LL-37 reconstitution calculations have been logged by the WPA community. The most common dose entered is 500mcg (6 calculations). The median dose across all sessions is 300mcg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 5mg (15 sessions). The most common dosing frequency is daily (7x/week) (1 logged protocols).
World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.